| 101/222 | US=56 / Biol/Mol Wang JW, Cheng JQ. A simple method for profiling miRNA expression. In: Mor G, Alvero AB. Apoptosis and cancer: methods and protocols. New Jersey: Humana Press, 2008. p. 183-90. (Methods in Molecular Biology) ISBN 978-1-58829-457-9. EXPRESSAO DE MIRNA; DOT BLOT; HIBRIDIZACAO; BIBLIOTECA OLIGODESOXINUCLEOTIDO |
| 102/222 | US=56 / Biol/Mol Denault JB, Salvesen GS. Apoptotic caspase activation and activity. In: Mor G, Alvero AB. Apoptosis and cancer: methods and protocols. New Jersey: Humana Press, 2008. p. 191-220. (Methods in Molecular Biology) ISBN 978-1-58829-457-9. |
| 103/222 | US=56 / Biol/Mol Walczak H, Haas TL. Biochemical analysis of the native TRAIL death-inducing signaling complex. In: Mor G, Alvero AB. Apoptosis and cancer: methods and protocols. New Jersey: Humana Press, 2008. p. 221-39. (Methods in Molecular Biology) ISBN 978-1-58829-457-9. |
| 104/222 | US=56 / Biol/Mol Vega CJ. Laser microdissection sample preparation for RNA analyses. In: Mor G, Alvero AB. Apoptosis and cancer: methods and protocols. New Jersey: Humana Press, 2008. p. 241-52. (Methods in Molecular Biology) ISBN 978-1-58829-457-9. MICRODISSECCAO A LASER; MICRODISSECCAO E CAPTURA A LASER (MCL); EXPRESSAO GENICA; RNA; RNASE |
| 105/222 | US=84 / Biol/Mol Kim TA, Kim SJ. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: mechanisms of TGF-B-induced apoptosis in cancer cells. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 199-211. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. |
| 106/222 | US=86 / Biol/Mol Hersey P, Zhang XD, Mhaidat N. Overcoming resistance to apoptosis in cancer therapy. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 105-26. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. TERAPIA DO CANCER; RESISTENCIA A APOPTOSE; ONCOGENE; MELANOMA; FAMILIA BCL-2 |
| 107/222 | US=86 / Biol/Mol Shankar S, Srivastava RK. Histone deacetylase inhibitors: mechanisms and clinical significance in cancer: HAC inhibitor-induced apoptosis. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 261-98. (Advances in Experimental Medicina and Biology volume 615) ISBN 978-1-4020-6553-8. INIBIDORES DE HISTONA DESACETILASE; CANCER; APOPTOSE INDUZIDA POR INIBIDORES; INIBIDORES HDAC; HAT; SAHA; MS-275; TSA; TRAIL; CASPASE |
| 108/222 | US=86 / Biol/Mol Jagani Z, Khosravi-Far R. Cancer stem cells and impaired apoptosis. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 331-44. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. CELULAS-TRONCO; CANCER; APOPTOSE; TERAPIA; LEUCEMIA; WNT; BMI1 |
| 109/222 | US=98 / Biol/Mol Kerr JFR. A personal history of the development of the apoptosis concept. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 1-11. ISBN 978-084939192-7. HISTORIA CONCEITO DE APOPTOSE; DESENVOLVIMENTO DO CONCEITO DE APOPTOSE; ENCOLHIMENTO; NECROSE; TUMORES MALIGNOS |
| 110/222 | US=98 / Biol/Mol Wilson GD. What do the clinical data tell us about the role of apoptosis in sensitivity to cancer therapy?. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 13-39. ISBN 978-084939192-7. |
| 111/222 | US=98 / Biol/Mol Brown M. Response of solid tumors to cancer therapy: how relevant is apoptosis. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 41-53. ISBN 978-084939192-7. |
| 112/222 | US=98 / Biol/Mol Lockshin RA, Zakeri Z. Historical studies of various forms of cells death. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 55-72. ISBN 978-084939192-7. |
| 113/222 | US=98 / Biol/Mol Bredesen DE. Toward a mechanistic taxonomy for programmed cell death pathways. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 73-91. ISBN 978-084939192-7. |
| 114/222 | US=98 / Biol/Mol Egger L. Caspase-independent apoptotic cell death. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 93-108. ISBN 978-084939192-7. CASPASE-INDEPENDENTE DE MORTE CELULAR POR APOPTOSE; INIBICAO DA CASPASE; SINTETICOS INIBIDORES DE CASPASES; CASPASE-MORTE CELULAR INDEPENDENTE |
| 115/222 | US=98 / Biol/Mol Madden DT. Autophagic cell death in mammalian cells. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 109-26. ISBN 978-084939192-7. MORTE CELULAR; CELULAS DE MAMIFEROS AUTOFAGICA; AUTOFAGIA E CANCER |
| 116/222 | US=98 / Biol/Mol Fan Y, Ullman E, Zong WX. The cellular decision between apoptosis and autophagy. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 127-41. ISBN 978-084939192-7. |
| 117/222 | US=98 / Biol/Mol Dawson VL, Dawson TM. Parthanatos: PARP - and AIF-dependent programmed cell death. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 143-56. ISBN 978-084939192-7. PARTHANATOS; PARP; FIA; MORTE CELULAR PROGRAMADA; POLYMERASE-1 |
| 118/222 | US=98 / Biol/Mol Sperandio S, Belle I. Paraptosis. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 157-74. ISBN 978-084939192-7. |
| 119/222 | US=98 / Biol/Mol Campisi J. Cellular senescence and its effects on carcinogenesis. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 175-93. ISBN 978-084939192-7. SENESCENCIA CELULAR; CARCINOGENESE. EFEITOS; SENESCENCIA CELULAR E OS SEUS EFEITOS SOBRE A CARCINOGENESE; SENESCENCIA CELULAR SUPRIME CANCER; CANCER E ENVELHECIMENTO; SENESCENCIA CELULAR E CANCER |
| 120/222 | US=98 / Biol/Mol Nickoloff BJ. Tumor suppressing activities of senescent keratinocytes. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 195-207. ISBN 978-084939192-7. TUMORAIS SUPRIMINDO; ATIVIDADES DE QUERATINOCITOS SENESCENTES |